Feb 26, 2019

Sudden leadership shake-up hits NOAA

Hurricane Florence makes landfall in North Carolina in 2018. Image: NOAA via Getty Images

Tim Gallaudet, the acting administrator of the National Oceanic and Atmospheric Administration (NOAA), was suddenly replaced on Monday by the No. 3 official at the agency, former weather industry scientist Neil A. Jacobs.

Why it matters: The agency has been operating without a Senate-confirmed administrator for the longest time since it was created in 1970. Gallaudet, a retired U.S. Navy rear admiral, had earned plaudits for advancing the agency's priorities in ocean and atmospheric sciences without succumbing to political interference with climate research, as other agencies have during the Trump administration.

  • NOAA is responsible for regulating fisheries, forecasting the weather, and studying oceans and climate. It is perhaps best known for the National Weather Service and its hurricane hunter aircraft.

Details: An email went out to NOAA employees on Monday to announce the leadership swap, stating that it was ordered by Commerce Secretary Wilbur Ross. It gave no reason for the change, however.

"Today, Commerce Secretary Ross asked me to perform the nonexclusive functions and duties of Under Secretary and NOAA Administrator. As Senate confirmed Assistant Secretaries, I will continue to serve as the Assistant Secretary of Commerce for Environmental Observation and Prediction, while Admiral Gallaudet will continue to serve as the Assistant Secretary of Commerce for Oceans and Atmosphere."
"In no way will this impact our mission or shift our priorities."

The all-staff email said that Gallaudet will now focus his time on oceans issues, taking him out of a climate communications role.

  • A NOAA spokesperson tells Axios the switch is a "natural shift that occurs in agencies and departments over time. Both leaders are dedicated professionals who believe in the people, science and missions at NOAA. The agency's important work on behalf of the American people and businesses will occur seamlessly into the future."

Between the lines: NOAA gave little notice to its overseers on Capitol Hill, with Sen. Maria Cantwell, the top Democrat on the Senate Commerce Committee, only receiving word an hour before the move was announced.

  • Gallaudet made news in December when, under repeated climate change-related questioning from reporters at a science conference, admitted that he has never briefed President Trump on the issue, despite the agency's role as a major scientific research entity that funds and conducts climate studies.

Why you'll hear more about this: The Trump administration has nominated Barry Myers, the former CEO of the private weather forecasting company AccuWeather, to serve as NOAA administrator.

  • The Senate has not voted on the nomination, in part due to concerns over conflicts of interest stemming from his business career and investments.
  • Myers resigned from AccuWeather and divested his interests in the company in January. However, his brother continues to lead the company.

My thought bubble: The elevation of Jacobs, who previously ran weather programs at Panasonic Avionics, could position the administration to pull Myers' nomination if opposition is too strong to overcome.

Go deeper: Rapid global warming is bringing unprecedented changes to Arctic

Go deeper

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 3 a.m. ET: 665,164 — Total deaths: 30,852 — Total recoveries: 140,225.
  2. U.S.: Leads the world in cases. Total confirmed cases as of 3 a.m. ET: 124,665 — Total deaths: 2,191 — Total recoveries: 1,095.
  3. Federal government latest: President Trump announces new travel advisories for New York, New Jersey and Connecticut, but rules out quarantine enforcement. Per the CDC, residents of those states must now "refrain from non-essential domestic travel for 14 days," with the exception of critical infrastructure industry workers.
  4. State updates: Alaska is latest state to issue a stay-at-home order — New York is trying to nearly triple its hospital capacity in less than a month and has moved its presidential primary to June 23. Some Midwestern swing voters who backed Trump's handling of the virus less than two weeks ago are balking at his call for the U.S. to be "opened up" by Easter.
  5. World updates: In Spain, over 1,400 people were confirmed dead between Thursday to Saturday.
  6. 🚀 Space updates: OneWeb filed for bankruptcy amid the novel coronavirus pandemic.
  7. Hollywood: Tom Hanks and Rita Wilson have returned to U.S. after being treated for coronavirus.
  8. What should I do? Answers about the virus from Axios expertsWhat to know about social distancingQ&A: Minimizing your coronavirus risk
  9. Other resources: CDC on how to avoid the virus, what to do if you get it.

Subscribe to Mike Allen's Axios AM to follow our coronavirus coverage each morning from your inbox.

Coronavirus updates: Global death toll tops 30,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens and confirmed plus presumptive cases from the CDC

The novel coronavirus has now killed more than 30,000 people around the world — with Italy reporting over 10,000 deaths, per Johns Hopkins data.

The big picture: The number of deaths from COVID-19 in the U.S. surpassed 2,000 on Saturday. The United States leads the world in confirmed coronavirus infections — more than 124,000 by early Sunday. The number of those recovered from the virus in the U.S. passed the 1,000-mark on Saturday evening.

Go deeperArrowUpdated 2 hours ago - Health

Gilead expands access to experimental coronavirus drug in emergency cases

Photo: Olivier Douliery/AFP via Getty Images

Gilead Sciences CEO Daniel O’Day said in an open letter Saturday the company is expanding access to its experimental anti-coronavirus drug remdesivir to include severely ill COVID-19 patients.

The big pig picture: President Trump has called the antiviral drug "promising," but the results of six clinical trials on this investigational medicine are still being conducted, so its effectiveness the treatment of the novel coronavirus has yet to be proved. The World Health Organization is involved in the tests.

Go deeperArrow3 hours ago - Health